Synagis 50 mg/0.5 ml, Injektionslösung

7680656950015 CH-65695 Injektionslösung
Synagis 50 mg/0.5 ml, Injektionslösung
Synagis 50 mg/0.5 ml, Injektionslösung
Synagis 50 mg/0.5 ml, Injektionslösung
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
05/08/2022
Summary of Product Characteristics
Français
05/08/2022
Summary of Product Characteristics
Italien
05/08/2022
Patient information leaflet
Allemand
20/10/2021
Patient information leaflet
Français
20/10/2021
Patient information leaflet
Italien
20/10/2021

Detailed composition

Substance Quantity Type Category
(N/A)
50.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 624.00
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/08/2017

Authorization holder

AstraZeneca AG

6340 Baar

Authorization information

Swissmedic authorization number
65695
Drug name
Synagis, Injektionslösung
Galenic form
LSPA
ATC Code
J06BD01
Authorization status
Z
Dispensing category
A
First authorization
05/07/2016
Authorization expiration date
31/12/9999
IT Number
08.03.0.
Domain
Human medicine
Field of application
RSV-Prophylaxe

Package details

Description (FR)
SYNAGIS sol inj 50 mg/0.5ml flac
Description (DE)
SYNAGIS Inj Lös 50 mg/0.5ml Durchstf
Market launch
05/07/2016
Narcotic (BTM)
No

Other package sizes (1)

SYNAGIS sol inj 100 mg/1ml flac
1 DUR
GTIN: 7680656950022
View